Default company panoramic image

Avisa Pharma Inc

We have developed the first, rapid, point of care test for pneumonia that provides for appropriate use of antibiotics to combat antibiotic resistant infections

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Santa Fe, NM, USA
  • Currency USD
  • Founded October 2010
  • Employees 6
  • Incorporation Type C-corp
  • Website

Company Summary

Avisa is a venture-backed company developing and commercializing the first rapid, point-of-care breath test for the diagnosis of pulmonary infections.
The rise of antibiotic resistant infections costs the U.S. healthcare system over $20 billion each year. We are seeking $1,000,000 of a $3,000,000 Convertible Note financing of which $2,000,000 has been invested by current shareholders for runway expansion for $15 million Series B round underway.


  • Default avatar
    David S Joseph
    President and CEO

    Co-Founder of Avisa Pharma with 40 years of lifescience experience, co-founder and CEO of four lifescience companies in medical technology, biomaterials and biopharmaceuticals. Successful exits include two public companies and two acquisitions.

  • Default avatar
    Graham S Timmins, Ph.D.
    Chief Science Advisor

    Co-founder and Associate Professor, Pharmaceutical Sciences, University of New Mexico. Patented and developed Avisa's stable, non-radioactive isotope technology platform. Recipient of multiple federal grants, over 50 scientific publications.

  • Default avatar
    Elizabeth A Perkett, MD
    Chief Medical Officer

    Former Professor of Pulmonary Medicine, Vanderbilt University, Cystic Former professor of pulmonary medicine, Vanderbilt University. Full time Avisa CMO, over 50 recent clinical publications.

  • Default avatar
    Matt Culler
    VP Finance

    Former investment bank analyst, venture partner and VP Finance and Operations of a clean tech company

  • B57298e2 36dd 4f40 830b 867a326b4c98
    VP Engineering and Product Management

    20 years of medical device experience and laser spectoscopy


  • Default avatar
    Kate Shay, Duane Morris, Philadelphia

Previous Investors

  • Default avatar
    Sun Mountain Capital, Santa Fe, New Mexico